The WHO has sought “additional clarifications" from Bharat Biotech for Covaxin to conduct a final risk-benefit assessment for Emergency Use Listing of the vaccine.
Latest News of India, Sports, Tech, Technology 2021 from Top India News- News18.com for more info CLICK HERE
0 Comments